Records containing: Ocular Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-07-15An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase III, Prospective, Double-Masked, Randomized, Multi-Center, Active-Controlled, Parallel Group Comparison Study Assessing the Ocular Hypotensive Efficacy of Reformulated PG324 Ophthalmic Solution in Subjects With Elevated Intraocular Pressure
-
CLINICAL_TRIALS study record update · 2026-04-20Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Medication Burden in Medically Controlled Patients With Ocular Hypertension or Primary Open Angle Glaucoma
-
CLINICAL_TRIALS study record update · 2026-04-01Pivotal Clinical Study to Evaluate the Smartlens miLens Measurement Performance and Safety Over a 24-hour Wear Period
-
CLINICAL_TRIALS study record update · 2026-03-2324-hour Effect Of Rocklatan Compared With Latanoprost In Open Angle Glaucoma And Ocular Hypertension Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-23A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2026-03-05Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
-
CLINICAL_TRIALS study record update · 2026-03-05Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
-
CLINICAL_TRIALS study record update · 2026-01-14A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Ocular Hypotensive Efficacy of Two Concentrations of SBI-100 Ophthalmic Emulsion in Patients With Elevated Intraocular Pressure
-
CLINICAL_TRIALS study record update · 2026-01-13A Multicenter, Randomized, Single-blind, Active Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2026-01-02Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2025-12-29Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
-
CLINICAL_TRIALS study record update · 2025-12-16Direct Selective Laser Trabeculoplasty for Primary Open Angle Glaucoma and Ocular Hypertension and Normal Tension Glaucoma in Ethnic Chinese Population - The Zhuiguangzhe Trial
-
CLINICAL_TRIALS study record update · 2025-11-18A Phase II, Prospective, Two-Stage, Double-Masked, Randomized, Multi-Center, Controlled, Dose-Response Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-17043 and PG043 (AR-17043/Latanoprost) Ophthalmic Solutions in Subjects With Elevated Intraocular Pressure
-
CLINICAL_TRIALS study record update · 2025-10-20A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,
-
CLINICAL_TRIALS study record update · 2025-10-20A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,
-
CLINICAL_TRIALS study record update · 2025-10-15Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2025-10-07New Diagnostic Paradigms for the Identification of Early Glaucomatous Damage
-
CLINICAL_TRIALS study record update · 2025-10-03Optimal Treatment Protocol for Selective Laser Trabeculoplasty
-
CLINICAL_TRIALS study record update · 2025-09-30Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
-
CLINICAL_TRIALS study record update · 2025-09-08A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)
-
CLINICAL_TRIALS study record update · 2025-09-04Observational Study to Evaluate Long-term Follow-up of Subjects Implanted With Sustained-release Bimatoprost With the SpyGlass IOL in Subjects With Ocular Hypertension or Mild-to-moderate Open-angle Glaucoma
-
CLINICAL_TRIALS study record update · 2025-09-04A Prospective Trial to Evaluate the Safety and Effectiveness of the Sustained Release Bimatoprost Implant With SpyGlass IOL in Patients With Ocular Hypertension or Mild to Moderate Open-Angle Glaucoma
-
CLINICAL_TRIALS study record update · 2025-08-28An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2025-08-27A Phase 2b Randomized, Double-masked, Active-controlled, Dose-response Study of the Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension